TGFB1 and age-related macular degeneration: We found that TGF-β/Smad pathway through regulation of pro-angiogenic factors played a critical role in the development of experimental CNV, suggesting TGF-β/Smad signaling pathway blockage may provide a novel, effective auxiliary treatment for AMD.